Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1362881

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1362881

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Drug Eluting Stent Market Growth & Trends:

The global drug eluting stent market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. An aging population and the increasing prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive the demand for drug eluting stents over the forecast period. Additionally, ongoing technological advancements in stent design, including improvements in coatings and drug delivery mechanisms, are enhancing the safety and efficacy of these devices, making them more appealing to patients and healthcare professionals.

The increasing prevalence of cardiovascular diseases globally has fueled market demand. According to the World Health Federation report in 2022, over half a billion people globally continue to be affected by cardiovascular diseases, with CVD contributing to approximately 20.5 million deaths in 2021, accounting for nearly a third of all deaths globally. Conditions like coronary artery disease and peripheral artery disease are becoming increasingly common, leading to a surge in demand for effective treatment options such as DES. These stents, equipped with drug-coated surfaces, offer patients a minimally invasive solution, effectively preventing restenosis and leading to improved patient outcomes.

The market for drug eluting stents was significantly impacted by the COVID-19 pandemic, with disruptions in the supply chain of medical devices. Since the focus of all major manufacturers was to fight the COVID-19 battle, the revenues of other segments were highly impacted. All notable competitors in the market for coronary stents announced a decline in revenue for their interventional cardiology portfolios, which include coronary stent devices in 2020, owing mostly to the impact of the COVID-19 pandemic.

Drug Eluting Stent Market Report Highlights:

  • Based on coating, the polymer-based coating segment held the dominant revenue share of 82.9% in 2022. This share can be attributed to its extensive usage in stent development, proven efficacy in drug delivery, and versatility in accommodating various therapeutic agents, making it a preferred choice for manufacturers and healthcare professionals alike. Additionally, continuous advancements in polymer-based coating technology have further solidified its leading position in the market
  • Based on application, the market for drug eluting stents has been categorized into coronary artery disease and peripheral artery disease, with the former accounting for 85.9% of the revenue share in 2022. The growth can be attributed to the high prevalence of coronary artery disease globally, leading to a substantial demand for effective treatment options such as drug eluting stents
  • The North American region held the largest revenue share of 43.08% in 2022 and is expected to dominate the market through the forecast period. North America has a well-developed and advanced healthcare infrastructure, including hospitals. Additionally, the increasing prevalence of cardiovascular diseases in the region has driven the demand for effective treatment options such as drug eluting stents
Show more
Product Code: 978-1-68038-999-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of Cardiovascular Diseases
    • 3.4.2. Technological Advancements in Stent Design
    • 3.4.3. Growing Geriatric Population
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Drug Eluting Stents
  • 3.6. Penetration And Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Drug Eluting Stent Market: Coating Type Segment Analysis

  • 4.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 4.2. Polymer-Based Coating
    • 4.2.1. Polymer-Based Coating Market, 2018 - 2030 (USD Billion)
      • 4.2.1.1. Non-Biodegradable Polymers
      • 4.2.1.2. Biodegradable Polymers
  • 4.3. Polymer-free Coating
    • 4.3.1. Polymer-Free Coating Market, 2018 - 2030 (USD Billion)
      • 4.3.1.1. Micro Porous Surface
      • 4.3.1.2. Micro Structured Surface
      • 4.3.1.3. Slotted Tubular Surface
      • 4.3.1.4. Nanoporous Surface

Chapter 5. Drug Eluting Stent Market: Application Segment Analysis

  • 5.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 5.2. Coronary Artery Disease
    • 5.2.1. Coronary Artery Disease Market, 2018 - 2030 (USD Billion)
  • 5.3. Peripheral Artery Disease
    • 5.3.1. Peripheral Artery Disease Market, 2018 - 2030 (USD Billion)

Chapter 6. Drug Eluting Stent Market: Regional Analysis

  • 6.1. Drug Eluting Stent Market Share, By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Drug Eluting Stent Market, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Abbott Laboratories
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Terumo Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Biosensors International
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Cook Medical
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. B. Braun
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Biotronik
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Lepu Medical Technology
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-999-9

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Drug eluting stent market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global drug eluting stent market: Coating type movement analysis
  • Fig. 16 Global drug eluting stent market, for polymer-based coating, 2018 - 2030 (USD Billion)
  • Fig. 17 Global drug eluting stent market, for polymer-free coating, 2018 - 2030 (USD Billion)
  • Fig. 18 Global drug eluting stent market: Application movement analysis
  • Fig. 19 Global drug eluting stent market, for coronary artery disease, 2018 - 2030 (USD Billion)
  • Fig. 20 Global drug eluting stent market, for peripheral artery disease, 2018 - 2030 (USD Billion)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 Regional outlook, 2022 & 2030
  • Fig. 23 Global drug eluting stent market: Regional movement analysis
  • Fig. 24 North America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 25 U.S. drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 26 Canada drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 30 France drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 38 China drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 39 India drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 45 Mexico drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 46 Argentina drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 47 Middle East and Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 48 South Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 49 Saudi Arabia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 50 UAE drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 51 Kuwait drug eluting stent market, 2018 - 2030 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!